Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-55
SponsorSichuan Provincial People's Hospital

About this trial

This study explored the association between postoperative functional recovery and the formula of analgesic pumps as well as other related factors (such as age, intraoperative blood loss, operation duration, etc.) by retrospectively analyzing the clinical data of patients undergoing cesarean section in the main campus and branches of Sichuan Provincial People's Hospital from September 2024 to June 2025. The value of this study lies in: 1) providing a basis for optimizing the postoperative analgesia plan after cesarean section. 2) To provide references for the formulation of personalized analgesia strategies in clinical practice, improve the postoperative recovery quality of patients, promote the concept of enhanced recovery after surgery, and reduce the medical burden.

Eligibility criteria

Qualifiers

Age 18-55 years

ASAI-III level

Scheduled or emergency cesarean section

Postoperative use of analgesic pump (formulation includes buprenorphine or tramadol or hydromorphone, etc.)

Disqualifiers

Postoperative analgesia pump usage time is less than 24 hours

Missing key information such as follow-up status in medical records

Trial design

Treatments tested in this trial

  • An postoperative analgesic pump was used

Treatment groups

2,500 Participants
are divided into 1 treatment group

Locations

This trial has no locations